Prolonged Survival in Bi-Allelic TP53-Mutated (TP53mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)

• Published in: Blood Vol. 140; no. Supplement 1; pp. 2066 - 2069
• Main Authors: Savona, Michael R., McCloskey, James K, Griffiths, Elizabeth A., Yee, Karen, Zeidan, Amer M., Al-Kali, Aref, Deeg, Joachim, Patel, Prapti, Sabloff, Mitchell, Keating, Mary-Margaret, Dao, Kim-Hien, Zhu, Nancy, Gabrail, Nashat Y., Fazal, Salman, Maly, Joseph J., Odenike, Olatoyosi, Kantarjian, Hagop, DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Buckstein, Rena, Amin, Harshad, Randhawa, Jasleen K., Leber, Brian, Oganesian, Aram, Chan, Winny, Hao, Yong, Azab, Mohammad, Garcia-Manero, Guillermo
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 15.11.2022
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2022-163841